Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 4,308,000 $ 2,801,000 $ 7,258,000 $ 6,708,000
General and administrative 1,140,000 1,538,000 2,348,000 2,742,000
Total operating expenses 5,448,000 4,339,000 9,606,000 9,450,000
Loss from operations (5,448,000) (4,339,000) (9,606,000) (9,450,000)
Other income (expense):        
Interest income, net 151,000 140,000 371,000 140,000
Foreign exchange gain (loss) (46,000) 33,000 (64,000) (45,000)
Total other expense, net 105,000 173,000 307,000 95,000
Net loss $ (5,343,000) $ (4,166,000) $ (9,299,000) $ (9,355,000)
Net loss per common share, basic $ (0.53) $ (0.41) $ (0.91) $ (1.03)
Net loss per common share, diluted $ (0.53) $ (0.41) $ (0.91) $ (1.03)
Weighted average number of common shares outstanding, basic 10,174 10,065 10,174 9,109
Weighted average number of common shares outstanding, diluted 10,174 10,065 10,174 9,109